Huons Strengthens Communication with FGI for Continuous Glucose Monitor 'Dexcom G6'

[Asia Economy Reporter Chunhee Lee] Huons has strengthened communication with type 1 diabetes patients for the product development of the continuous glucose monitoring system (CGMS) Dexcom G6.

On the 23rd, Huons held a 'Dexcom G6 FGI (Focus Group Interview)' with 13 patients, including Kim Mi-young, the representative of the Type 1 Diabetes Patient Association, participating via video call, the company announced on the 25th. The FGI was organized to directly hear and empathize with the daily lives changed by using Dexcom G6 from type 1 diabetes patients, aiming to foster an organic relationship between the continuous glucose monitoring system and type 1 diabetes patients.

The FGI was conducted in a format of free discussion on ▲distribution plans for diabetes management supplies such as CGMS ▲differences before and after using the continuous glucose monitoring system ▲reasons for recommending Dexcom to type 1 diabetes patients ▲and expectations for Dexcom. Huons plans to actively incorporate the patients' difficulties and requests raised during the discussion into future marketing activities for Dexcom G6.

Kim Mi-young, the representative of the patient association, said, “I am pleased that the continuous glucose monitoring system company has created a place to communicate and empathize with patients,” and added, “I hope the stories shared in the FGI will be reflected in the future activities of Dexcom G6.”

A Huons official stated, “Starting with this FGI, we plan to continuously create opportunities to explore the development of the domestic continuous glucose monitoring system market and the direction Dexcom G6 should take together with type 1 diabetes patients,” and said, “We will carry out patient-friendly marketing that can contribute to the healthy daily lives of type 1 diabetes patients.”

This content was produced with the assistance of AI translation services.